FDA says Gilead's (GILD) HIV combo pill has 'generally acceptable' safety
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Join SI Premium – FREE
Bloomberg reporting the FDA has said Gilead's (Nasdaq: GILD) HIV combo pill has "generally acceptable" safety.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- CoVolt Power files for proposed IPO
- Home Depot expands executive roles, grants $500K in restricted stock
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
